Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
PainChek Ltd ( (AU:PCK) ) has provided an announcement.
PainChek Ltd has successfully raised A$7.5 million through a placement supported by institutional and high net worth investors, aimed at driving international growth. The funds will be used to support the commercialization of its pain assessment device in the US, pending FDA clearance, and to expand its market presence in Canada, Australia, New Zealand, and the UK. This expansion is expected to significantly enhance PainChek’s market position and revenue, with the potential to tap into the US long-term care market valued at $582 million annually.
More about PainChek Ltd
PainChek Ltd is a developer of a smart device-based pain assessment and monitoring application, operating in the healthcare technology industry. The company focuses on AI-enabled pain assessment devices, targeting markets such as long-term care in the US, and expanding its presence in Australia, New Zealand, and the UK.
Average Trading Volume: 1,758,745
Technical Sentiment Signal: Buy
Current Market Cap: A$73.68M
Find detailed analytics on PCK stock on TipRanks’ Stock Analysis page.